Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
-0.68 (-1.38%)
5:20:17 PM EDT: $48.76 +0.17 (+0.35%)
Mergers / Acquisitions

Resapp Health Says Pfizer Raises Scheme Consideration To A$0.208 Per Share

Published: 08/05/2022 08:03 GMT
Pfizer Inc. (PFE) - Pfizer Raises Scheme Consideration to A$0.208 per Share.
Pfizer Has Agreed to Increase Scheme Consideration From A$0.146 per Share to A$0.208 per Share in Cash.
Court Approves Dispatch of Supplementary Scheme Booklet.
Revised Scheme Consideration Implies an Equity Value on a 100% Fully Diluted Basis of Approximately A$180 Mln.
Revised Scheme Consideration is Equal to Independent Expert's Preferred Value of a Resapp Share.
Directors of Resapp Continue to Unanimously Recommend That Resapp Shareholders Vote in Favour of Scheme.